These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34002379)

  • 1. SARS-CoV-2 vaccines are not free of neurological side effects.
    Finsterer J; Scorza FA
    Acta Neurol Scand; 2021 Jul; 144(1):109-110. PubMed ID: 34002379
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological side effects of SARS-CoV-2 vaccinations.
    Finsterer J
    Acta Neurol Scand; 2022 Jan; 145(1):5-9. PubMed ID: 34750810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and use of vaccines from the 18th century to the SARS-CoV 2 period].
    Skinhøj P; Bygbjerg IC
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Vaccines.
    Creech CB; Walker SC; Samuels RJ
    JAMA; 2021 Apr; 325(13):1318-1320. PubMed ID: 33635317
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
    Nojszewska M; Kalinowska A; Adamczyk-Sowa M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["About the Article Vaccines against Covid-19 available in Europe"].
    Hill C
    Rev Prat; 2021 Apr; 71(4):359. PubMed ID: 34160997
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral side effects of COVID-19 vaccine.
    Riad A
    Br Dent J; 2021 Jan; 230(2):59. PubMed ID: 33483637
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
    Maykin MM; Heuser C; Feltovich H;
    Vaccine; 2021 Jan; 39(2):171-172. PubMed ID: 33308888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: SARS-CoV-2 vaccines and cancer patients.
    Corti C; Curigliano G
    Ann Oncol; 2021 Apr; 32(4):569-571. PubMed ID: 33450404
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccines: call for global push to maintain efficacy.
    Stöhr K; Cox N
    Nature; 2021 Feb; 590(7844):36. PubMed ID: 33531701
    [No Abstract]   [Full Text] [Related]  

  • 14. Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    Kramer DB; Opel DJ; Parasidis E; Mello MM
    N Engl J Med; 2021 Apr; 384(17):e62. PubMed ID: 33657289
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Covid-19 vaccines available in March 2021"].
    Ibrahimi N; Chaltiel D; Hill C
    Rev Prat; 2021 Mar; 71(3):239-244. PubMed ID: 34161019
    [No Abstract]   [Full Text] [Related]  

  • 16. Mix-and-match COVID vaccines trigger potent immune response.
    Callaway E
    Nature; 2021 May; 593(7860):491. PubMed ID: 34012131
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.
    Salian VS; Wright JA; Vedell PT; Nair S; Li C; Kandimalla M; Tang X; Carmona Porquera EM; Kalari KR; Kandimalla KK
    Mol Pharm; 2021 Mar; 18(3):754-771. PubMed ID: 33464914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biosecurity of COVID-19 vaccines.
    Kantor IN
    Medicina (B Aires); 2020; 80 Suppl 6():104-106. PubMed ID: 33481741
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Canaday DH; Gravenstein S
    Clin Infect Dis; 2021 Feb; 72(3):513-514. PubMed ID: 33527123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.